Cizzle Biotechnology Holdings Plc (FRA:E7F0)
0.0160
0.00 (0.00%)
At close: Nov 28, 2025
Cizzle Biotechnology Holdings Company Description
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom.
It develops a non-invasive blood test for early lung cancer detection using CIZ1B biomarker technology.
The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Cizzle Biotechnology Holdings Plc
| Country | United Kingdom |
| Industry | In Vitro and In Vivo Diagnostic Substances |
| Employees | 4 |
Contact Details
Address: The Shard London, SE1 9SG United Kingdom | |
| Phone | 44 203 9346630 |
| Website | cizzlebiotechnology.com |
Stock Details
| Ticker Symbol | E7F0 |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | GBP |
| SIC Code | 2835 |